Status:
UNKNOWN
Contribution of Attachment and Educational Practices in the Expression of ADHD in School-aged Children
Lead Sponsor:
Queen Fabiola Children's University Hospital
Collaborating Sponsors:
The Belgian Kids' Fund
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
7-10 years
Phase:
NA
Brief Summary
ADHD is a neurodevelopmental disorder characterized by the presence of persistent signs of associated hyperactivity-impulsivity and/or inattention that impair the child's functioning or development. ...
Eligibility Criteria
Inclusion
- Male or female patients ages 7 to ≤10 years with ADHD (study group) or TD children matched by gender and socio-economic factors (control group) and their parents.
- French-speaking population Willing and able to comply with scheduled visits and study procedures. Written informed consent/assent, according to local guidelines, signed by the patient and / or by the parents or legal guardian prior to any study related screening procedures are performed.
Exclusion
- Children with intellectual disabilities (IQ \<80). Epilepsy. Prematurity. Objectified neurological sequelae. Specific language impairment or severe learning disabilities. Contraindication to stopping treatment for ADHD
Key Trial Info
Start Date :
May 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04337125
Start Date
May 15 2020
End Date
December 31 2022
Last Update
June 9 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Universitaire Des Enfants Reine Fabiola
Brussels, Belgium, 1020
2
Hôpital Erasme
Brussels, Belgium, 1070